Search Results
You are looking at 1 - 3 of 3 items for
- Author: MC Lacroix x
- Refine by access: All content x
Search for other papers by M.C. Lacroix in
Google Scholar
PubMed
Search for other papers by G. Charpigny in
Google Scholar
PubMed
Search for other papers by P. Reinaud in
Google Scholar
PubMed
ABSTRACT
This study describes the presence in and production by the ovine conceptus of an oxytocin-like peptide during the early stages of development. Oxycotin was measured by radioimmunoassay in ovine conceptuses from days 14 to 30 of pregnancy. Tissue concentrations of oxytocin increased from day 14 (24.8 ± 5 pg/100 mg) until day 19 (122.9 ± 52 pg/100 mg) and then decreased (3 ± 1 pg /100 mg). Oxytocin was released into culture medium by day-15 ovine conceptuses at a rate of 262 ± 55 pg/24 h. Reverse-phase high-performance liquid chromatography (HPLC) analysis of peptides extracted from a pool of ovine conceptuses was conducted using chromatographic conditions developed to separate oxytocin from other nonapeptides. Radioimmunoassay of HPLC fractions for oxytocin revealed an immunoactive conceptus peptide in a single fraction at the same retention time as chromatographed authentic oxytocin. Radioimmunoassay and chromatographic data therefore suggest that this oxytocin-like peptide is similar, if not identical, to authentic oxytocin. Concentrations of oxytocin in conceptus tissue were maximal during the period of inhibition of luteal regression (days 14-19). It is proposed that conceptus oxytocin is involved in the maintenance of luteal function in early pregnancy.
Search for other papers by MC Soares in
Google Scholar
PubMed
Search for other papers by JL Servely in
Google Scholar
PubMed
Search for other papers by C Puissant in
Google Scholar
PubMed
Search for other papers by P Bolifraud in
Google Scholar
PubMed
Search for other papers by MC Lacroix in
Google Scholar
PubMed
Search for other papers by B Schaeffer in
Google Scholar
PubMed
Search for other papers by G Kann in
Google Scholar
PubMed
We report the ability of sheep placental cotyledonary cells, isolated at different periods of pregnancy (40 to 90 days) to produce ovine chorionic somatomammotrophin (oCS) in in vitro culture conditions. This oCS production increased gradually with stage of pregnancy. Endogenous oCS net production by isolated placental cells was increased, in a dose-dependent manner, by addition of recombinant oCS (roCS). This effect was not observed after addition of recombinant ovine growth hormone. The roCS effect was more potent on cells collected during early pregnancy. Specific immunoprecipitation of oCS revealed that roCS treatment was associated with an increased dose-dependent incorporation of [35S]methionine-[35S]cysteine. These findings provide evidence that oCS may act in a paracrine/autocrine manner to up-regulate its own production during early gestation. We suggest that this autoregulation may be associated with morphological and functional differentiation of the trophoblast during the growth of the placenta.
Search for other papers by J Blahovec in
Google Scholar
PubMed
Search for other papers by Z Kostecka in
Google Scholar
PubMed
Search for other papers by MC Lacroix in
Google Scholar
PubMed
Search for other papers by L Cabanie in
Google Scholar
PubMed
Search for other papers by F Godeau in
Google Scholar
PubMed
Search for other papers by J Mester in
Google Scholar
PubMed
Search for other papers by F Cavaille in
Google Scholar
PubMed
Amniotic fluid (AF) collected from ewes and goats at mid gestation displayed mitogenic activity in mouse fibroblasts. Upon fractionation of this material by size exclusion chromatography, the mitogenic activity was resolved into two peaks, whose activity was inhibited by an anti-IGF type 1 receptor blocking antibody. One of the peaks contained IGF-I and IGF-II (mature form), whereas the other contained high M(r) precursor forms of IGF-II. The presence in this latter fraction of IGF-binding proteins (IGFBP) suggests that the AF IGFBPs do not efficiently inhibit the mitogenic activity of the high M(r) forms of IGF-II. In agreement with this conclusion, exogenous IGFBP-1 failed to affect this activity. Analysis of IGF-II in sheep AF showed that the AF concentrations of both forms of IGF-II increased dramatically from mid pregnancy until 106-120 days of gestation, and fell thereafter. The amniotic IGFBPs followed a similar evolution. High M(r) forms of IGF-II were also found in human AF, with a pattern of electrophoretic migration different from that of sheep. We suggest that the precursor forms of IGF-II may play an important role in foetal development.
